Glucotrack
Nasdaq GCTK · Rutherford, NJ
Works in Immunology · Metabolic & endocrine
Glucotrack is a clinical trial sponsor based in Rutherford, NJ, listed as Nasdaq GCTK. It has 1 active clinical trial with 10 planned participants, in Immunology and Metabolic & endocrine.
Trial track record · since 2021
Financials · Nasdaq GCTK
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Glucotrack
Glucotrack is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 10 planned participants, in Immunology, Metabolic & endocrine. Since 2021 it has completed 0 trials and stopped 0 early.
Glucotrack is based in Rutherford, NJ and is listed as Nasdaq GCTK. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Glucotrack; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-01-08.
Approve Suite is not affiliated with Glucotrack. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.